Corvus Pharmaceuticals, Inc. Share Price
Corvus Pharmaceuticals, Inc. (CRVS) had Share Price of $7.70 per share as of 2025-12-31, per its DEF 14A filed 2026-04-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2026-04-24
- 2025-12-31: Share Price $7.70.
- 2024-12-31: Share Price $5.35.
- 2022-12-30: Share Price $0.85.
- 2016-03-29: Share Price $15.00.
| Period end | Share Price |
|---|---|
| 2025-12-31 | $7.70 DEF 14A · filed 2026-04-24 |
| 2024-12-31 | $5.35 10-K · filed 2025-03-25 |
| 2022-12-30 | $0.85 DEF 14A · filed 2026-04-24 |
| 2016-03-29 | $15.00 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |